Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: Q4Q6N6
Term | Name | Level | Count |
---|---|---|---|
GO:0001666 | response to hypoxia | 3 | 2 |
GO:0006950 | response to stress | 2 | 2 |
GO:0009628 | response to abiotic stimulus | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0033554 | cellular response to stress | 3 | 2 |
GO:0036293 | response to decreased oxygen levels | 4 | 2 |
GO:0036294 | cellular response to decreased oxygen levels | 5 | 2 |
GO:0042221 | response to chemical | 2 | 2 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 2 |
GO:0070482 | response to oxygen levels | 3 | 2 |
GO:0070887 | cellular response to chemical stimulus | 3 | 2 |
GO:0071453 | cellular response to oxygen levels | 4 | 2 |
GO:0071456 | cellular response to hypoxia | 4 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0005506 | iron ion binding | 6 | 5 |
GO:0008198 | ferrous iron binding | 7 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 5 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 4 | 2 |
GO:0019842 | vitamin binding | 3 | 5 |
GO:0030246 | carbohydrate binding | 2 | 5 |
GO:0031406 | carboxylic acid binding | 4 | 5 |
GO:0031418 | L-ascorbic acid binding | 3 | 5 |
GO:0031543 | peptidyl-proline dioxygenase activity | 3 | 2 |
GO:0036094 | small molecule binding | 2 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043168 | anion binding | 3 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0043177 | organic acid binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0046914 | transition metal ion binding | 5 | 5 |
GO:0048029 | monosaccharide binding | 3 | 5 |
GO:0051213 | dioxygenase activity | 3 | 5 |
GO:0097159 | organic cyclic compound binding | 2 | 5 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.387 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.303 |
CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.404 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.302 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.358 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.404 |
CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.396 |
CLV_PCSK_PC1ET2_1 | 159 | 161 | PF00082 | 0.273 |
CLV_PCSK_PC1ET2_1 | 18 | 20 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.273 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 309 | 313 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.340 |
CLV_Separin_Metazoa | 110 | 114 | PF03568 | 0.387 |
DEG_APCC_DBOX_1 | 308 | 316 | PF00400 | 0.381 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.504 |
DOC_CYCLIN_RxL_1 | 39 | 47 | PF00134 | 0.371 |
DOC_CYCLIN_RxL_1 | 9 | 16 | PF00134 | 0.384 |
DOC_MAPK_gen_1 | 156 | 166 | PF00069 | 0.279 |
DOC_MAPK_gen_1 | 17 | 25 | PF00069 | 0.394 |
DOC_MAPK_gen_1 | 220 | 229 | PF00069 | 0.328 |
DOC_MAPK_gen_1 | 307 | 314 | PF00069 | 0.395 |
DOC_MAPK_MEF2A_6 | 159 | 168 | PF00069 | 0.273 |
DOC_PP4_FxxP_1 | 185 | 188 | PF00568 | 0.273 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.476 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.532 |
LIG_14-3-3_CanoR_1 | 133 | 138 | PF00244 | 0.411 |
LIG_14-3-3_CanoR_1 | 160 | 165 | PF00244 | 0.326 |
LIG_14-3-3_CanoR_1 | 256 | 264 | PF00244 | 0.374 |
LIG_14-3-3_CterR_2 | 323 | 325 | PF00244 | 0.385 |
LIG_Actin_WH2_2 | 240 | 258 | PF00022 | 0.404 |
LIG_Actin_WH2_2 | 308 | 325 | PF00022 | 0.453 |
LIG_EH1_1 | 8 | 16 | PF00400 | 0.286 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.459 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.347 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.273 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.381 |
LIG_GBD_Chelix_1 | 108 | 116 | PF00786 | 0.373 |
LIG_GBD_Chelix_1 | 7 | 15 | PF00786 | 0.316 |
LIG_IRF3_LxIS_1 | 286 | 291 | PF10401 | 0.385 |
LIG_LIR_Gen_1 | 238 | 247 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 26 | 36 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 238 | 244 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 26 | 31 | PF02991 | 0.361 |
LIG_MYND_1 | 184 | 188 | PF01753 | 0.273 |
LIG_NRBOX | 298 | 304 | PF00104 | 0.406 |
LIG_PCNA_PIPBox_1 | 22 | 31 | PF02747 | 0.375 |
LIG_PCNA_yPIPBox_3 | 17 | 29 | PF02747 | 0.384 |
LIG_Pex14_2 | 225 | 229 | PF04695 | 0.273 |
LIG_Pex14_2 | 97 | 101 | PF04695 | 0.366 |
LIG_PTB_Apo_2 | 95 | 102 | PF02174 | 0.381 |
LIG_Rb_LxCxE_1 | 114 | 132 | PF01857 | 0.411 |
LIG_SH2_CRK | 151 | 155 | PF00017 | 0.273 |
LIG_SH2_GRB2like | 151 | 154 | PF00017 | 0.273 |
LIG_SH2_NCK_1 | 151 | 155 | PF00017 | 0.273 |
LIG_SH2_SRC | 151 | 154 | PF00017 | 0.273 |
LIG_SH2_SRC | 273 | 276 | PF00017 | 0.373 |
LIG_SH2_STAP1 | 269 | 273 | PF00017 | 0.319 |
LIG_SH2_STAP1 | 81 | 85 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.369 |
LIG_SH3_1 | 151 | 157 | PF00018 | 0.273 |
LIG_SH3_2 | 154 | 159 | PF14604 | 0.273 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.273 |
LIG_SUMO_SIM_anti_2 | 107 | 114 | PF11976 | 0.380 |
MOD_CK2_1 | 288 | 294 | PF00069 | 0.430 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.377 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.428 |
MOD_N-GLC_2 | 117 | 119 | PF02516 | 0.381 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.309 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.340 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.365 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.332 |
MOD_PKA_1 | 160 | 166 | PF00069 | 0.303 |
MOD_PKA_2 | 160 | 166 | PF00069 | 0.303 |
MOD_PKA_2 | 255 | 261 | PF00069 | 0.375 |
MOD_Plk_1 | 273 | 279 | PF00069 | 0.376 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.330 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.538 |
TRG_DiLeu_BaLyEn_6 | 10 | 15 | PF01217 | 0.371 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.389 |
TRG_ER_diArg_1 | 160 | 162 | PF00400 | 0.302 |
TRG_ER_diArg_1 | 210 | 213 | PF00400 | 0.330 |
TRG_ER_diArg_1 | 255 | 257 | PF00400 | 0.394 |
TRG_NLS_MonoExtN_4 | 156 | 163 | PF00514 | 0.275 |
TRG_Pf-PMV_PEXEL_1 | 313 | 317 | PF00026 | 0.487 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P964 | Leptomonas seymouri | 78% | 100% |
A0A0S4KJQ7 | Bodo saltans | 47% | 99% |
A0A3Q8ICC7 | Leishmania donovani | 94% | 100% |
A4I6C0 | Leishmania infantum | 94% | 100% |